AANEM News Express

AANEM News Express

Fighting to Ensure Quality in Neuromuscular and EDX Medicine

12/2/2014
 
AANEM’s health policy director, Millie Birr, JD, MPP, exhibited at the National Healthcare Antifraud Association’s (NHCAA) Anti-Fraud Expo in Dallas in mid-November.  More than 1,000 private and public payers and healthcare anti-fraud law enforcement personnel attended the conference, with 100 attendees stopping by the AANEM booth.

Birr shared materials and information on AANEM’s laboratory accreditation program, position statements, and general information on how to detect fraudulent and abusive practices in electrodiagnostic (EDX) medicine.  “This was great exposure for AANEM,” she stated. “After exchanging e-mails and phone calls over the past year, I had the opportunity to meet individuals from various insurance companies in person. They made a point of visiting the booth. I believe attending this conference helped solidify some of our payer relationships and created some new ones.”

AANEM members Ronald C. Bingham, MD, and Peter A. Grant, MD, presented at other NHCAA meetings this year to educate payers and law enforcement about the importance of accurate EDX studies in an effort to combat fraud and abuse. “AANEM is hoping that educating payers on how to identify EDX fraud will help them eliminate this costly part of their business and allow them to pay quality providers what they deserve for conducting these important tests for patients,” noted Shirlyn Adkins, AANEM’s executive director. 

What are you doing to educate payers in your area? Send an email to policy@aanem.org to let us know.


View Related News Stories:

  AdvocacyFraud and Abuse


Recent AANEM News

Recap: 2019 AMA House of Delegates Annual Meeting

Science News: Efficacy of Botulinum Toxin A for Treating Cramps in Diabetic Neuropathy

Science News: Diagnostic Sensitivity of Electrophysiology and Ultrasonography in Ulnar Neuropathies of Different Severity

Science News: Long-term Effect of Thymectomy Plus Prednisone Versus Prednisone Alone in Patients with Non-thymomatous Myasthenia Gravis: 2-year Extension of the MGTX Randomised Trial

AANEM Returns to Capitol for 6th Annual Hill Day





Advertisement

TPP

Advertisement

ABEM

Advertisement

Find Your Dream Job